"Pneumococcal Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Vaccines or candidate vaccines used to prevent infections with STREPTOCOCCUS PNEUMONIAE.
Descriptor ID |
D022242
|
MeSH Number(s) |
D20.215.894.135.750.600
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Pneumococcal Vaccines".
Below are MeSH descriptors whose meaning is more specific than "Pneumococcal Vaccines".
This graph shows the total number of publications written about "Pneumococcal Vaccines" by people in this website by year, and whether "Pneumococcal Vaccines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 0 | 2 | 2 |
1997 | 0 | 1 | 1 |
1998 | 0 | 1 | 1 |
2000 | 0 | 1 | 1 |
2001 | 3 | 1 | 4 |
2002 | 0 | 1 | 1 |
2003 | 5 | 1 | 6 |
2004 | 3 | 0 | 3 |
2005 | 5 | 0 | 5 |
2006 | 4 | 0 | 4 |
2007 | 3 | 2 | 5 |
2008 | 4 | 2 | 6 |
2009 | 1 | 1 | 2 |
2010 | 4 | 2 | 6 |
2011 | 4 | 1 | 5 |
2012 | 3 | 2 | 5 |
2013 | 4 | 3 | 7 |
2014 | 4 | 0 | 4 |
2015 | 3 | 0 | 3 |
2016 | 6 | 3 | 9 |
2017 | 3 | 1 | 4 |
2018 | 3 | 1 | 4 |
2019 | 1 | 2 | 3 |
2020 | 3 | 1 | 4 |
2021 | 2 | 1 | 3 |
2022 | 0 | 1 | 1 |
2023 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pneumococcal Vaccines" by people in Profiles.
-
A Phase 3, Randomized, Double-Blind, Comparator-Controlled Study to Evaluate Safety, Tolerability, and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Allogeneic Hematopoietic Cell Transplant Recipients (PNEU-STEM). Clin Infect Dis. 2023 10 13; 77(8):1102-1110.
-
Vaccine response after pneumococcal vaccination in allogeneic hematopoietic stem cell transplant recipients. J Oncol Pharm Pract. 2024 Jan; 30(1):15-18.
-
Burden of all-cause and organism-specific parapneumonic empyema hospitalization rates prior to the SARS-CoV-2 pandemic in the United States. Respir Med. 2023 02; 207:107111.
-
Subcutaneous immunoglobulin replacement for treatment of humoral immune dysfunction in patients with chronic lymphocytic leukemia. PLoS One. 2021; 16(10):e0258529.
-
Impact of 13-Valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Carriage Rates of Streptococcus pneumoniae in a Rural Community in the Dominican Republic. J Infect Dis. 2021 09 01; 224(12 Suppl 2):S237-S247.
-
Trends in pneumococcal vaccination in patients presenting with acute coronary syndrome in the United States. Prog Cardiovasc Dis. 2021 Jul-Aug; 67:111-113.
-
The Association of Medications and Vaccination with Risk of Pneumonia in Inflammatory Bowel Disease. Inflamm Bowel Dis. 2020 05 12; 26(6):919-925.
-
The Use of 20% Subcutaneous Immunoglobulin Replacement Therapy in Patients With B Cell Non-Hodgkin Lymphoma With Humoral Immune Dysfunction After Treatment With Rituximab. Clin Lymphoma Myeloma Leuk. 2020 09; 20(9):e590-e596.
-
Pneumococcal (Pneumonia) Vaccines. Am J Respir Crit Care Med. 2020 05 01; 201(9):P17-P18.
-
Previsit Planning Improves Pneumococcal Vaccination Rates in Childhood-Onset SLE. Pediatrics. 2020 01; 145(1).